MediWound (MDWD) Competitors $17.30 +0.06 (+0.32%) As of 11:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDWD vs. SANA, TBPH, MNMD, MAZE, RZLT, TRML, TYRA, GOSS, PROK, and DNAShould you be buying MediWound stock or one of its competitors? The main competitors of MediWound include Sana Biotechnology (SANA), Theravance Biopharma (TBPH), Mind Medicine (MindMed) (MNMD), Maze Therapeutics (MAZE), Rezolute (RZLT), Tourmaline Bio (TRML), Tyra Biosciences (TYRA), Gossamer Bio (GOSS), ProKidney (PROK), and Ginkgo Bioworks (DNA). These companies are all part of the "pharmaceutical products" industry. MediWound vs. Its Competitors Sana Biotechnology Theravance Biopharma Mind Medicine (MindMed) Maze Therapeutics Rezolute Tourmaline Bio Tyra Biosciences Gossamer Bio ProKidney Ginkgo Bioworks MediWound (NASDAQ:MDWD) and Sana Biotechnology (NASDAQ:SANA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk. Do analysts recommend MDWD or SANA? MediWound presently has a consensus target price of $32.25, indicating a potential upside of 86.36%. Sana Biotechnology has a consensus target price of $8.00, indicating a potential upside of 142.79%. Given Sana Biotechnology's stronger consensus rating and higher probable upside, analysts plainly believe Sana Biotechnology is more favorable than MediWound.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MediWound 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Sana Biotechnology 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor MDWD or SANA? In the previous week, Sana Biotechnology had 3 more articles in the media than MediWound. MarketBeat recorded 5 mentions for Sana Biotechnology and 2 mentions for MediWound. MediWound's average media sentiment score of 1.35 beat Sana Biotechnology's score of 0.57 indicating that MediWound is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MediWound 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sana Biotechnology 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is MDWD or SANA more profitable? Sana Biotechnology has a net margin of 0.00% compared to MediWound's net margin of -142.18%. Sana Biotechnology's return on equity of -91.96% beat MediWound's return on equity.Company Net Margins Return on Equity Return on Assets MediWound-142.18% -96.71% -39.73% Sana Biotechnology N/A -91.96%-43.07% Which has preferable valuation and earnings, MDWD or SANA? MediWound has higher revenue and earnings than Sana Biotechnology. MediWound is trading at a lower price-to-earnings ratio than Sana Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediWound$20.22M9.25-$30.22M-$2.64-6.55Sana BiotechnologyN/AN/A-$266.76M-$1.06-3.11 Do insiders & institutionals believe in MDWD or SANA? 46.8% of MediWound shares are held by institutional investors. Comparatively, 88.2% of Sana Biotechnology shares are held by institutional investors. 9.2% of MediWound shares are held by insiders. Comparatively, 30.1% of Sana Biotechnology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, MDWD or SANA? MediWound has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Comparatively, Sana Biotechnology has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500. SummarySana Biotechnology beats MediWound on 11 of the 15 factors compared between the two stocks. Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDWD vs. The Competition Export to ExcelMetricMediWoundMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$187.07M$2.56B$5.78B$10.38BDividend YieldN/A57.29%5.74%4.64%P/E Ratio-6.5523.0977.0826.78Price / Sales9.25546.30507.10167.11Price / CashN/A169.7137.1760.63Price / Book5.995.3713.696.40Net Income-$30.22M$32.95M$3.29B$271.62M7 Day Performance-3.00%1.61%3.23%3.33%1 Month Performance-0.26%7.76%8.37%10.15%1 Year Performance-2.34%-2.89%82.31%31.19% MediWound Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDWDMediWound1.6031 of 5 stars$17.31+0.3%$32.25+86.4%-1.8%$187.07M$20.22M-6.5580Positive NewsSANASana Biotechnology3.2072 of 5 stars$3.00+1.4%$8.00+166.7%-23.3%$703.91MN/A-2.83380TBPHTheravance Biopharma3.3849 of 5 stars$13.92-0.2%$21.33+53.3%+75.0%$702.54M$64.38M58.00110Short Interest ↑MNMDMind Medicine (MindMed)2.27 of 5 stars$9.39+1.8%$24.71+163.2%+55.9%$701.53MN/A-6.1440MAZEMaze Therapeutics3.552 of 5 stars$14.97-5.7%$26.33+75.9%N/A$696.35M$167.50M0.00121Analyst ForecastInsider TradeRZLTRezolute3.0548 of 5 stars$7.95-0.6%$12.50+57.2%+68.4%$695.97MN/A-6.9140News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpTRMLTourmaline Bio0.9319 of 5 stars$30.18+12.9%$50.14+66.1%+127.1%$687.00MN/A-8.8044High Trading VolumeTYRATyra Biosciences2.0468 of 5 stars$12.13-4.1%$31.43+159.1%-44.9%$674.21MN/A-6.8120GOSSGossamer Bio4.0239 of 5 stars$2.66-9.5%$8.50+219.5%+238.1%$668.50M$114.70M-4.29180Positive NewsPROKProKidney3.5354 of 5 stars$2.16-4.0%$6.25+189.4%+13.4%$662.14M$80K-3.793DNAGinkgo Bioworks1.7041 of 5 stars$11.19+0.3%$9.50-15.1%+54.7%$660.08M$227.04M-1.91640Positive News Related Companies and Tools Related Companies Sana Biotechnology Alternatives Theravance Biopharma Alternatives Mind Medicine (MindMed) Alternatives Maze Therapeutics Alternatives Rezolute Alternatives Tourmaline Bio Alternatives Tyra Biosciences Alternatives Gossamer Bio Alternatives ProKidney Alternatives Ginkgo Bioworks Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDWD) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediWound Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediWound With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDWD Stock Alerts